HENCE EFFECT IN ;
CV: Extrasystoles; hypotension; palpitations; tachycardia.
CNS: Confusion; convulsions; disturbed coordination; dizziness; euphoria; excitation; faintness; fatigue; hallucinations; headache; hysteria; insomnia; irritability; nervousness; neuritis; paresthesias; restlessness; sedation and sleepiness (often transient); tremor.
DERM: Excessive perspiration; photosensitivity; rash; urticaria.
EENT: Acute labyrinthitis; blurred vision; diplopia; dry mouth, nose, and throat; tinnitus; vertigo.
GI: Anorexia; constipation; diarrhea; epigastric distress; nausea; vomiting.
GU: Difficult urination; early menses; urinary frequency; urinary retention.
HEMA: Agranulocytosis; hemolytic anemia; leukopenia; thrombocytopenia.
HEPA: Abnormal hepatic function; cholestasis; hepatic failure; hepatitis; jaundice.
METAB: Increased appetite; weight gain.
RESP: Chest tightness; nasal stuffiness; thickening of bronchial secretions; wheezing.
OTHER: Anaphylactic shock; chills; edema.
Alcohol, CNS depressants
May cause additive CNS depressant effects.
Anticholinergic effects of cyproheptadine may increase. Concurrent use is contraindicated.
Therapeutic Classification: allergy, cold and cough remedies, antihistamines
Absorption: Apparently well absorbed after oral dosing.
Metabolism/Excretion: Mostly metabolized by the liver.
Copyright ©Nims Drugs2015. All rights reserved.
Powered by : web creation Nepal